ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CARLOS SABATES MD

Cardiovascular Disease

66,982

$2.89M

1662
1565 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $65

RODOLFO DUMENIGO M.D.

Cardiovascular Disease

52,581

$2.16M

1529
1355 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$41
Average prescription price

Avg: $65

JORGE PASTORIZA MD

Cardiovascular Disease

36,633

$1.45M

1220
1183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$40
Average prescription price

Avg: $65

GEORGE PIZARRO M.D.

Cardiovascular Disease

35,201

$2.69M

843
737 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $65

ENRIQUE HUERTAS MD

Cardiovascular Disease

34,165

$1.77M

996
904 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $65

HUGO GARCIA MD

Cardiovascular Disease

29,149

$1.37M

1120
1063 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$47
Average prescription price

Avg: $65

HOWARD REINFELD MD

Cardiovascular Disease

26,932

$1.7M

941
630 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$63
Average prescription price

Avg: $65

EDGARDO CESPEDES MD

Cardiovascular Disease

24,469

$2.94M

646
550 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 28%

$120
Average prescription price

Avg: $65

PEDRO DIAZ M.D.

Cardiovascular Disease

24,311

$1.2M

1097
1009 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$49
Average prescription price

Avg: $65

GABRIEL COSTA M.D.

Cardiovascular Disease

21,959

$1.03M

658
613 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$47
Average prescription price

Avg: $65

VIJAY VAKHARIA MD

Cardiovascular Disease

21,420

$693K

1211
1106 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$32
Average prescription price

Avg: $65

PABLO VIVAS MD

Cardiovascular Disease

20,016

$1.13M

1267
1165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $65

LEONARD PIANKO M.D.

Cardiovascular Disease

19,871

$1.18M

824
718 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$59
Average prescription price

Avg: $65

RICARDO MACHADO M.D.

Cardiovascular Disease

19,466

$1.21M

1231
1164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $65

MIGUEL RODRIGUEZ MAY MD

Cardiovascular Disease

18,111

$1.74M

437
341 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 28%

$96
Average prescription price

Avg: $65

JOSE PINERO MD

Cardiovascular Disease

17,656

$1.16M

749
688 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $65

MICHAEL BAHRAMI MD

Cardiovascular Disease

16,397

$984K

616
365 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$60
Average prescription price

Avg: $65

ROGER GALVEZ MD

Cardiovascular Disease

15,991

$912K

950
892 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $65

ANDRES TAMAYO MD

Cardiovascular Disease

15,405

$1.07M

444
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $65

ORLANDO ALMANZA MD

Cardiovascular Disease

15,317

$868K

882
824 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $65

JULIO BUZZI MD

Cardiovascular Disease

15,208

$762K

438
413 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $65

GERARDO POLANCO MD

Cardiovascular Disease

15,096

$881K

1002
929 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 28%

$58
Average prescription price

Avg: $65

VICTOR PAZOS MD

Cardiovascular Disease

14,914

$839K

1028
938 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $65

JUAN QUINTANA M.D.

Cardiovascular Disease

13,962

$928K

671
624 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $65

OSCAR GUERRA MD

Cardiovascular Disease

13,694

$965K

670
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 28%

$70
Average prescription price

Avg: $65

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank